m-RNA Synthesis Service Market, By Application (Therapeutic Development, Vaccine Production, Drug Discovery, Others), By Scale of Operation (Research, Commercial), By End User (Biopharmaceutical Companies, Contract research organizations (CROs), Others), By Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)-

Published In : Feb 2023

Code : CMI5537

Pages :177

Formats :

Excel and PDF

Industry : Biotechnology

Market News

Global m-RNA Synthesis Service Market: Key Developments

Increasing number of discoveries in m-RNA manufacturing is expected to drive the market growth over forecast period. In August 2022, New England Biolabs, a company producing and supplying recombinant and native enzyme reagents for life science research, announced the release of Faustovirus Capping Enzyme (FCE), an mRNA capping solution that combines high activity and a broad temperature range to support mRNA therapeutic manufacturing needs.

Market players are focused on manufacturing vaccines, which will increase the demand of m–RNA synthesis over the forecast period. For instance, in May 2022, EUROAPI, a company developing, producing, and marketing active pharmaceutical ingredients, expanded its collaboration with Sanofi, a multinational pharmaceutical and healthcare company, in order to support Sanofi’s mRNA vaccine platform with development of lipid nanoparticles. In this collaboration, EUROAPI will develop and optimize innovative chemical synthesis routes and will manufacture GMP (Good Manufacturing Practices) batches for various second-generation cationic lipids through its Contract Development and Manufacturing Organization (CDMO) activity.